{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:37:31Z","timestamp":1777268251291,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejca.2025.115232","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:43:25Z","timestamp":1736477005000},"page":"115232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cancers attributed to modifiable factors in Norway 2016\u20132020"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-4455","authenticated-orcid":false,"given":"Paula","family":"Berstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3414-4523","authenticated-orcid":false,"given":"Kristin","family":"Haugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus D.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-7308","authenticated-orcid":false,"given":"Reza","family":"Ghiasvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trude Eid","family":"Robsahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.115232_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2025.115232_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115232_bib3","unstructured":"Str\u00f8m M.S.S.K., Raknes G., Slung\u00e5rd G.F., Fager\u00e5s S.J. D\u00f8ds\u00e5rsaker i Norge 2022. Folkehelseinstituttet; 2023."},{"key":"10.1016\/j.ejca.2025.115232_bib4","unstructured":"Cancer Registry of Norway. Cancer in Norway 2023 - Cancer incidence, mortality, survival and prevalence in Norway Cancer Registry of Norway, Norwegian Institute of Public Health; 2024."},{"key":"10.1016\/j.ejca.2025.115232_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcpo.2018.09.001","article-title":"Cancer prevention policy in the EU: best practices are now well recognised; no reason for countries to lag behind","volume":"18","author":"Espina","year":"2018","journal-title":"J Cancer Policy"},{"key":"10.1016\/j.ejca.2025.115232_bib6","unstructured":"WHO I. IARC Monographs on the identification of carcinogenic hazards to humans [Available from: https:\/\/monographs.iarc.who.int\/list-of-classifications."},{"key":"10.1016\/j.ejca.2025.115232_bib7","unstructured":"World Cancer Research Fund\/ American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Body fatness and weight gain and the risk of cancer 2018."},{"key":"10.1016\/j.ejca.2025.115232_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ije\/dyaa107","article-title":"Cohort Profile: Norwegian offshore petroleum workers (NOPW) cohort","volume":"50","author":"Stenehjem","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.ejca.2025.115232_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019005","article-title":"Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway","volume":"8","author":"Hansen","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejca.2025.115232_bib10","unstructured":"Cancer Registry of Norway. Cancer in Norway 2020 - Cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway; 2021."},{"issue":"2(2","key":"10.1016\/j.ejca.2025.115232_bib11","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1038\/bjc.2011.489","article-title":"16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010","volume":"105","author":"Parkin","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib13","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cam4.1961","article-title":"Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-potential for prevention","volume":"8","author":"Dovey de la Cour","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2025.115232_bib15","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1007\/s00405-017-4748-8","article-title":"Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival","volume":"274","author":"Fossum","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ejca.2025.115232_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib17","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjos\u00e9","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib18","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ejca.2025.115232_bib19","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","article-title":"Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions","volume":"51","author":"Serrano","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2025.115232_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","article-title":"The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015","volume":"118","author":"Brown","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2018.09.009","article-title":"Cancers related to lifestyle and environmental factors in France in 2015","volume":"105","author":"Soerjomataram","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.31088","article-title":"How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013","volume":"142","author":"Wilson","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2019.04.007","article-title":"The current and future burden of cancer attributable to modifiable risk factors in Canada: summary of results","volume":"122","author":"Poirier","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2025.115232_bib25","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(18)30488-1","article-title":"Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ejca.2025.115232_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.35772\/ghm.2021.01037","article-title":"Burden of cancer attributable to modifiable factors in Japan in 2015","volume":"4","author":"Inoue","year":"2022","journal-title":"Glob Health Med"},{"key":"10.1016\/j.ejca.2025.115232_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41598-021-04564-2","article-title":"Updated fraction of cancer attributable to lifestyle and environmental factors in Denmark in 2018","volume":"12","author":"Tybjerg","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2025.115232_bib28","first-page":"405","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2025.115232_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s12885-020-07187-4","article-title":"Cancer cases and deaths attributable to lifestyle risk factors in Chile","volume":"20","author":"Rezende","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2025.115232_bib30","unstructured":"Statistics Norway. R\u00f8yk, alkohol og andre rusmidler [Available from: \u3008https:\/\/www.ssb.no\/statbank\/table\/05307\/\u3009."},{"key":"10.1016\/j.ejca.2025.115232_bib31","unstructured":"Norwegian Directory of Health. Tobacco Control in Norway 2023 [updated 23.08.2023. Available from: https:\/\/www.helsedirektoratet.no\/english\/tobacco-control-in-norway."},{"key":"10.1016\/j.ejca.2025.115232_bib32","unstructured":"Ferlay J.E.M., Lam F., Laversanne M., Colombet M., Mery L., Pi\u00f1eros M., Znaor A., Soerjomataram I., Bray F. Cancer incidence and mortality data Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. 2024 [Available from: https:\/\/gco.iarc.who.int\/today,."},{"key":"10.1016\/j.ejca.2025.115232_bib33","unstructured":"WHO. Prevalence of overweight among adults, BMI >\u2009= 25 (age-standardized estimate) (%) 2024 [Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/prevalence-of-overweight-among-adults-bmi-=\u2009-25-(age-standardized-estimate)-(-)."},{"key":"10.1016\/j.ejca.2025.115232_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144680","article-title":"The association of low-to-moderate alcohol consumption with breast cancer subtypes defined by hormone receptor status","volume":"10","author":"Strumylaite","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2025.115232_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08897077.2019.1697998","article-title":"To thine own self, be true: examining change in self-reported alcohol measures over time as related to socially desirable responding bias among people with unhealthy alcohol use","volume":"42","author":"Schell","year":"2021","journal-title":"Subst Abus"},{"key":"10.1016\/j.ejca.2025.115232_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12963-016-0090-4","article-title":"Estimating average alcohol consumption in the population using multiple sources: the case of Spain","volume":"14","author":"Sordo","year":"2016","journal-title":"Popul Health Metr"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:47:28Z","timestamp":1777265248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"alternative-id":["S0959804925000139"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115232","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancers attributed to modifiable factors in Norway 2016\u20132020","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115232"}}